Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Ridaura Generic Name & Formulations
Legal Class
Rx
General Description
Auranofin 3mg; caps.
Pharmacological Class
DMARD (gold salt).
How Supplied
Caps—60
Manufacturer
Ridaura Indications
Indications
Active rheumatoid arthritis unresponsive to NSAIDs.
Ridaura Dosage and Administration
Adult
Initially 6mg daily in 1–2 divided doses. If response inadequate after 6 months, may increase to 3mg 3 times daily. If still ineffective after 3 months, discontinue.
Children
Not recommended.
Ridaura Contraindications
Contraindications
History of gold-induced disorders.
Ridaura Boxed Warnings
Boxed Warning
Gold toxicity. Physicians should be experienced in chrysotherapy.
Ridaura Warnings/Precautions
Warnings/Precautions
Be fully familiar with chrysotherapy and this product's toxicity and benefits before use. Impaired renal or hepatic function. Inflammatory bowel disease. Rash. History of bone marrow depression. Monitor CBC with differential, platelet count, urinalysis, renal, liver function and for GI bleeding. Discontinue immediately if thrombocytopenia, proteinuria, or hematuria occurs. Pregnancy (Cat.C), nursing mothers: not recommended.
Ridaura Pharmacokinetics
See Literature
Ridaura Interactions
Not Applicable
Ridaura Adverse Reactions
Adverse Reactions
Bone marrow depression, proteinuria, hematuria, diarrhea, GI upset, ulcerative colitis, rash, pruritus, exfoliative dermatitis, stomatitis, conjunctivitis, proteinuria, nephrotic syndrome, cholestatic jaundice, gold bronchitis, pneumonitis, peripheral neuropathy.
Ridaura Clinical Trials
See Literature
Ridaura Note
Not Applicable
Ridaura Patient Counseling
See Literature
